Equity Overview
Price & Market Data
Price: $0.0994
Daily Change: -$0.0₃1 / 0.10%
Daily Range: $0.0898 - $0.0995
Market Cap: $12,650,300
Daily Volume: 1,025
Performance Metrics
1 Week: -9.96%
1 Month: 33.79%
3 Months: 4.75%
6 Months: -43.86%
1 Year: -42.05%
YTD: -14.59%
Details
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.